7-6002538-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_000535.7(PMS2):c.452G>A(p.Arg151His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000931 in 1,611,512 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000535.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250806Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135640
GnomAD4 exome AF: 0.00000891 AC: 13AN: 1459332Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 726022
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74392
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
This missense variant replaces arginine with histidine at codon 151 of the PMS2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in 10 of 26 Chinese individuals affected with Lynch syndrome (PMID: 20698049) and in a Chinese breast/ovarian cancer case (PMID: 32068069). This variant has been identified in 3/250806 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
The p.R151H variant (also known as c.452G>A), located in coding exon 5 of the PMS2 gene, results from a G to A substitution at nucleotide position 452. The arginine at codon 151 is replaced by histidine, an amino acid with highly similar properties. This alteration has been detected in 1/937 unselected Chinese breast cancer patients and in 10/26 Chinese patients who met at least Bethesda guidelines for Lynch syndrome (Sheng X et al. World J. Gastroenterol. 2010 Aug;16(30):3847-52; Li JY et al. Int J Cancer. 2019 Jan 15;144(2):281-289). This alteration was identified in a cohort of Chinese breast cancer patients (Chen B et al. Aging (Albany NY), 2020 Feb;12:3140-3155). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Uncertain:1
- -
Lynch syndrome 1 Uncertain:1
- -
Lynch syndrome Uncertain:1
This missense variant replaces arginine with histidine at codon 151 of the PMS2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in 10 of 26 Chinese individuals affected with Lynch syndrome (PMID: 20698049) and in a Chinese breast/ovarian cancer case (PMID: 32068069) suggesting that this variant may be a common polymorphism in that population. This variant has been identified in 3/250806 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
not provided Uncertain:1
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21153778, 19389263, 31857677, 29752822, 20698049, 35449176, 11574484, 32091409) -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 151 of the PMS2 protein (p.Arg151His). This variant is present in population databases (rs35629870, gnomAD 0.006%). This missense change has been observed in individual(s) with Lynch syndrome or a personal and/or family history of breast and ovarian cancer (PMID: 20698049, 29752822, 32068069, 35449176). ClinVar contains an entry for this variant (Variation ID: 156510). Invitae Evidence Modeling incorporating data from in vitro experimental studies (internal data) indicates that this missense variant is not expected to disrupt PMS2 function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Lynch syndrome 4 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at